Everything below concerns hGH fragment. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-11-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
=== Absorption === Bicalutamide is extensively and well-absorbed following oral administration, and its absorption is not affected by food. The absolute bioavailability of bicalutamide in humans is unknown due to its very low water solubility and hence lack of an assessable intravenous formulation. However, the absolute bioavailability of bicalutamide has been found to be high in animals at low doses (109% in mice at 10 mg/kg; 72% in rats at 1 mg/kg; 100% in dogs at 0.1 mg/kg), but diminishes with increasing doses such that the bioavailability of bicalutamide is low at high doses (10% in rats at 250 mg/kg; 31% in dogs at 100 mg/kg). In accordance, absorption of (R)-bicalutamide in humans is slow and extensive but saturable, with steady-state levels increasing linearly at a dosage of up to 150 mg/day and non-linearly at higher dosages. At higher dosages of 100 to 200 mg/day, absorption of bicalutamide is approximately linear, with a small but increasing departure from linearity above 150 mg/day. In terms of geometric mean steady-state concentrations of (R)-bicalutamide, the departures from linearity were 4%, 13%, 17%, and 32% with dosages of 100, 150, 200, and 300 mg/day, respectively. There is a plateau in steady-state levels of (R)-bicalutamide with bicalutamide dosages above 300 mg/day, and, accordingly, dosages of bicalutamide of 300 to 600 mg/day result in similar circulating concentrations of (R)-bicalutamide and similar degrees clinically of efficacy, tolerability, and toxicity.
When cocaine is mixed with diluents for the purpose of injection, the "...diluents can produce serious abscesses and pain if the user misses the vein and injects into muscle tissue." "Diluents and adulterants are often added to No. 3 heroin", including sugar, quinine, barbital and caffeine, some of which "can cause serious side effects." Dr. Hirsch, the New York Medical Examiner, claimed that buying illegal drugs is "... like playing Russian roulette," because "there is no way of knowing just what a heroin dealer has slipped into the packets." In some cases, if a dealer does not take the time to dilute the drug with lactose or other fillers, a "very potent blend of heroin" is sold, which can lead to overdoses. Claims that illegal drugs are routinely cut with substances such as rat poison and crushed glass, often cited in antidrug pamphlets, are largely unsubstantiated. Some countries, cities and organizations deploy drug checking services in order to improve the ability of users to make a more accurate risk assessment.
== Further reading == Gadd GM, Griffiths AJ (1 December 1977). "Microorganisms and heavy metal toxicity". Microbial Ecology. 4 (4): 303–317. Bibcode:1977MicEc...4..303G. doi:10.1007/BF02013274. ISSN 1432-184X. PMID 24232222. Some microbes tolerate metals that would be toxic to humans.
Sources: en.wikipedia.org
In September 2016, when asked if he thought the world had entered a new cold war, Russian Foreign Minister, Sergey Lavrov, argued that current tensions were not comparable to the Cold War. He noted the lack of an ideological divide between the United States and Russia, saying that conflicts were no longer ideologically bipolar. In August 2016, Daniel Larison of The American Conservative magazine wrote that tensions between Russia and the United States would not "constitute a 'new Cold War'" especially between democracy and authoritarianism, which Larison found more limited than and not as significant in the 2010s as that of the Soviet-Union era. Andrew Kuchins, an American political scientist and Kremlinologist speaking in December 2016, believed the term was "unsuited to the present conflict" as it may be more dangerous than the Cold War. In October 2016, John Sawers, a former MI6 chief, said he thought the world was entering an era that was possibly "more dangerous" than the Cold War, as "we do not have that focus on a strategic relationship between Moscow and Washington". Similarly, Igor Zevelev, a fellow at the Wilson Center, said that "it's not a Cold War [but] a much more dangerous and unpredictable situation". CNN opined: "It's not a new Cold War. It's not even a deep chill. It's an outright conflict", due to "competing military operations in Syria, disputes over Eastern European independence and escalating cyber breaches". In January 2017, former US government adviser Molly K.
Logan Roy is a fictional character and one of the main characters of the American HBO satirical dark comedy-drama television series Succession. He is portrayed by Brian Cox and was created by showrunner Jesse Armstrong. Armstrong initially conceived the series as a feature film about the Murdoch family. He later decided to create a new script centered on original characters, with Logan being loosely based on Rupert Murdoch and Sumner Redstone. Logan Roy is the self-made billionaire founder of media and entertainment conglomerate Waystar RoyCo and the patriarch of the Roy family. He is a harsh leader who primarily focuses on his company rather than his four children Connor, Kendall, Roman and Siobhan. He is distrustful of his children and his subordinates, refusing to step down as CEO at the start of the series despite his advanced age as well as health. His conflicts with his family, his employees at Waystar, other businesses, and the United States Department of Justice form the central story-line of the series. The character and Brian Cox's performance has been critically acclaimed, and has been cited as one of the best villains and characters in television. For his performance, Cox won the Golden Globe Award for Best Actor in a Drama Series and was nominated for three Primetime Emmy Awards for Outstanding Lead Actor in a Drama Series.
== History == EARS-Net is the collaborative effort of 29 countries. The information documented are antibiotic resistance which are determined according to the EUCAST standard. Around 80% of the participants utilize the EUCAST standard for detection of antibiotic resistance. EARS-Net was established in 1998 as EARSS, funded by the European Commission's Directorate General for Health and Consumer Affairs and the Dutch Ministry of Health, Welfare and Sports. However, in January 2010, it was transferred to the European Centre for Disease Prevention and Control (ECDC) where it was renamed EARS-Net.
==== Isospin singlet state of the deuteron ==== Due to the similarity in mass and nuclear properties between the proton and neutron, they are sometimes considered as two symmetric types of the same object, a nucleon. While only the proton has electric charge, this is often negligible due to the weakness of the electromagnetic interaction relative to the strong nuclear interaction. The symmetry relating the proton and neutron is known as isospin and denoted I (or sometimes T). Isospin is an SU(2) symmetry, like ordinary spin, so is completely analogous to it. The proton and neutron, each of which have isospin-1/2, form an isospin doublet (analogous to a spin doublet), with a "down" state (↓) being a neutron and an "up" state (↑) being a proton. A pair of nucleons can either be in an antisymmetric state of isospin called singlet, or in a symmetric state called triplet. In terms of the "down" state and "up" state, the singlet is
Sources: en.wikipedia.org
=== East Asia === An early Chinese etiological myth for the phases of the moon involved a great forest or tree which quickly grew and lost its leaves and flowers every month. After the Sui and Tang dynasties, this was sometimes connected to a woodsman named Wu Gang, sentenced to cut at a self-repairing tree as a punishment for varying offenses. The tree was originally identified as a 桂 (guì) and described in the terms of the osmanthus (Osmanthus fragrans, now known in Chinese as the 桂花 or "gui flower"), whose blossoms are still used to flavor wine and confections for the Mid-Autumn Festival. However, in English, it is often associated with the more well-known cassia (Cinnamomum cassia, now known in Chinese as the 肉桂 or "meat gui") while, in modern Chinese, it has instead become associated with the Mediterranean laurel. By the Qing dynasty, the chengyu "pluck osmanthus in the Toad Palace" (蟾宫折桂, Chángōng zhé guì) meant passing the imperial examinations, which were held around the time of the lunar festival. The similar association in Europe of laurels with victory and success led to its translation into Chinese as the 月桂 or "Moon gui".
== Diet == The house cricket is an omnivore that eats a range of plant and animal matter. Crickets in the wild consume flowers, leaves, fruits, grasses and other insects (including dead members of their own species). Crickets in captivity will accept fruits (e.g. apples, oranges, bananas), vegetables (e.g. potatoes, carrots, squash, leafy vegetables), grains (e.g. oatmeal, cornmeal, cooked corncobs, alfalfa, wheat germ, rice cereal), various pet foods and commercial cricket food.
However, unique cultural-specific phenotypes of disordered eating emerged prior to Western influence. For example, restrictive eating patterns were found in Japan as early as the 18th century and fewer reports of eating disorders were found between 1868 and 1944, when rapid Westernization occurred. Sex-specific stressors and cultural dynamics could be implicated in this independent development of anorexia nervosa symptomology.
The spores are elliptical to spindle-shaped, with dimensions of 12–17 by 5–7 μm. The basidia, the spore-bearing cells, are produced in a layer lining the tubes, and arrange themselves so their ends are facing the center of the tube; this layer of cells is known technically as a hymenium. The basidia are thin-walled, mostly attached to four spores, and measure 25–30 by 8–10 μm. Another cell type present in the hymenium is the cystidia, larger sterile cells that protrude beyond the basidia into the lumen of the hymenium and act as air traps, regulating humidity. B. edulis has pleurocystidia (cystidia located on the face of a pore) that are thin-walled, roughly spindle-shaped to ventricose, and 30–45 by 7–10 μm; the "stuffed" feature of the hymenium is caused by cheilocystidia—cells found on the edges of the pores. The hyphae of B. edulis do not have clamp connections.
=== Flavoprotein-related diseases === Due to the importance of flavoproteins, it is unsurprising that approximately 60% of human flavoproteins cause human disease when mutated. In some cases, this is due to a decreased affinity for FAD or FMN and so excess riboflavin intake may lessen disease symptoms, such as for multiple acyl-CoA dehydrogenase deficiency. In addition, riboflavin deficiency itself (and the resulting lack of FAD and FMN) can cause health issues. For example, in ALS patients, there are decreased levels of FAD synthesis. Both of these paths can result in a variety of symptoms, including developmental or gastrointestinal abnormalities, faulty fat break-down, anemia, neurological problems, cancer or heart disease, migraine, worsened vision and skin lesions. The pharmaceutical industry therefore produces riboflavin to supplement diet in certain cases. In 2008, the global need for riboflavin was 6,000 tons per year, with production capacity of 10,000 tons. This $150 to 500 million market is not only for medical applications, but is also used as a supplement to animal food in the agricultural industry and as a food colorant.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.